Testing
Company Profile
CEO Message
Management Team
Intellectual Property Rights Protection
Accomplishments
Corporate Culture
Customer Testimonials
Science Seminar Series
Discovery Chemistry
Analytical
Service Biology
Pharmaceutical Development
Process Development
Manufacturing
Press Releases
WuXi PharmaTech In the News
Supporting Equipment
Case Study
Project Timeline Management
Quality Control and Assurance
CADD Lab
Project Tracking System
username
password
Login
Home
About Us
Products & Services
News
Supports
Investor Relations
Careers
Contact Us
2008
2007
2006
2005
2004
2008
2007
Press Releases
WuXi PharmaTech In the News
About Us
Products & Services
News
Supports
Careers
Press Releases
7/2/2008
WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR
July 2, 2008 - Shanghai, China - WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it has appointed Mr. Bob Zhu as Vice President of Human Resources.
6/24/2008
Covance and WuXi PharmaTech To Form A Joint Venture to Provide World-class Preclinical Services in China
6/10/2008
WuXi PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
5/26/2008
WuXi PharmaTech (NYSE: WX) Appoints Dr. Peng Wang as VP of Discovery Biology
5/21/2008
The First QPatch HT in China Placed in WuXi PharmaTech (NYSE: WX)
5/21/2008
Stanford Professor Barry M. Trost Visits WuXi PharmaTech and Gives Two Seminars
4/26/2008
WuXi PharmaTech (NYSE: WX) Honored among the BCG 50 Local Dynamos
4/16/2008
WuXi PharmaTech (NYSE: WX) Endows a New Faculty Position at Tongji University
4/4/2008
WX Crowned "Chemistry CRO of the Year" by Pfizer
3/31/2008
Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
Total
17
First Prev
Next
Last
Pageļ¼
1
/2
Page
10
/Page
Copyright © 2008 WuXi PharmaTech Co., Ltd. All rights reserved.